Stock Market News

Eli Lilly to acquire gene-editing therapy developer Verve Therapeutics for up to $1.3 billion, companies say

Jun 17, 2025 - 12:02
 0
Eli Lilly to acquire gene-editing therapy developer Verve Therapeutics for up to $1.3 billion, companies say
Read More

Tags:

Previous Article

Dollar Becalmed, Gold Softer, Oil Firmer

Next Article

Barclays turns positive on U.S. Growth stocks, favored over Value

Related Posts

Renault boss De Meo quits, with reports of switch to Gucci-owner Kering

Renault boss De Meo quits, with reports of switch to Gu...

Jun 16, 2025  0

Trump announces $14.5 billion Etihad order for 28 Boeing planes with GE engines

Trump announces $14.5 billion Etihad order for 28 Boein...

May 16, 2025  0

AMC theaters to increase pre-movie commercials - Bloomberg

AMC theaters to increase pre-movie commercials - Bloomberg

Jun 3, 2025  0